Jobs with Startups
JobsStartupsInvestorsMCP
Startups

Sigma Genetics

Sigma Genetics logo

Sigma Genetics

Sigma Genetics is a biotechnology company that is building…

sigmagenetics.com
HQ: Seattle, WA, USA
1-10
Healthcare

Company research

Public company, workplace, funding, and market signals

Overview

Sigma Genetics is a Seattle-based biotechnology startup building Magnetoporation/Magnetoporator devices that use external pulsed magnetic fields to deliver DNA, RNA, proteins, and other charged molecules into cells. Public sources describe a very small, research-heavy team focused on translational cell-therapy, blood-product, and biomanufacturing use cases. Current sources show Zachary Rapp as CEO, while older YC/profile sources vary on founder naming, so founder/leadership attribution should be treated carefully.

Primary product

Magnetoporation / Magnetoporator device for intracellular delivery

Founded

2016

Headquarters

Seattle, Washington, United States

Team size

1-10

Industry

Biotechnology

Sub-industry

Gene delivery / cell therapy manufacturing platform

Offices

454 N 34th St, Seattle, Washington 98103-8602, US
Seattle, Washington, United States

Business model

Platform/device development
research collaborations
technology licensing
grant-funded R&D

Funding

Stage

Seed / grant-backed

Total raised

$3.7M

Latest round

Non-equity assistance / incubator-accelerator · Mar 2026

People & investors

Leadership

Zachary Rapp

Co-Founder & CEO

Matthew Scholz

Co-Founder, Board of Directors

Chris Pihl

Board Member

Zach H.

Director of Operations

Heather Marie Wilson, PhD

Senior Scientist

Amanda Frey, PhD

Scientist

Mei Xu, MD, PhD

Scientific Consultant

James Overaa

Mechatronics Engineer

Dr. Joseph Rappold

Advisor

Investors

Andy Hill CARE Fund
Biosphere Investment Group
Capital Factory
IKJ Capital
Invariantes Fund
Plug and Play Seattle
Turkiye Wealth Fund
U.S. Department of Defense / AFWERX
USAF
Y Combinator

Work & culture

Small, research-heavy biotech startup focused on translational cell and gene delivery; public sources emphasize magnetic-field-based platform development, academic/defense collaborations, and a tiny team.

Visa sponsorship

Limited

Compensation

Public pay signals are sparse. Salary.com estimates an average annual salary of about $103,972, with a range of $91,599-$117,415, and MyVisaJobs shows a 2024 H-1B proffered salary of $115,297 for a Mechatronics Engineer.

Benefits

401(k)
healthcare
disability insurance
pension
paid time off
Social Security

Product & market

Pricing

Not publicly disclosed; appears to combine platform/device commercialization, research collaborations, and grant-funded R&D, with projected downstream economics cited as about $5,000 per CAR-T dose and about $500 per freeze-dried RBC unit in investor materials.

Differentiators

  • —Magnetoporation uses external pulsed magnetic fields for intracellular delivery
  • —non-invasive compared with electroporation
  • —no arcing
  • —scalable and adjustable across cell volumes
  • —gentler handling with low cell death
  • —can deliver DNA, RNA, proteins, and cryoprotectants
  • —applicable to RBCs, cell therapy, vaccines, and biomanufacturing

Technology

Google Workspace
jQuery
Nginx
PHP
Bluehost
WordPress
MySQL

Customers

cell therapy developers
biopharma manufacturers
research institutions
blood product / transfusion R&D programs

Competitors

BTX
Thermo Fisher
Lonza
Miltenyi
MaxCyte
Genedit
CellFE
Portal
LogicBio

Scale & contact

Estimated revenue

<$5M

Estimated monthly visits

1.5K

Traffic estimate as of Jun 2026

zach@sigmagenetics.com206-369-8277

Latest news

UW researchers work with Sigma Genetics on cold-chain-free stabilization of RNA-lipid nanoparticle formulations

University of Wyoming News · Jul 2026

Recent university coverage says Sigma Genetics is a company partner on a project to stabilize RNA-lipid nanoparticles in dry state form for transport and storage.

LinkedIn company profile financial snapshot

LinkedIn · Mar 2026

LinkedIn’s company page shows Sigma Genetics as active, founded in 2016, with 5 employees and funding entries for 2017, 2022, and 2026.

WO2025245377A1 patent publication for magnetoporation delivery systems

Google Patents · Nov 2025

A pending patent application names Sigma Genetics as assignee and lists Christopher James Pihl, Matthew Rein Scholz, and Zachary Rapp as inventors.

LSINW company one-pager on Sigma Genetics

Life Science Washington Institute · Mar 2025

The profile states Sigma Genetics is a Seattle-based Delaware C-corp founded in 2016, with $1.89M venture capital and $1.73M non-dilutive grant funding and a 2025 goal of raising a $10M Series A.

Sigma Genetics receives SBIR Phase I award for magnetoporation-based lyophilized red blood cells

SBIR.gov · Jan 2025

USAF awarded Sigma Genetics $64,111 for a project using magnetoporation and trehalose delivery to create functional lyophilized red blood cells.

LinkedIn company pageLSINW one-pagerMyVisaJobs employer profileOfficial websitePatent applicationProspeo profileSalary.com profileSBIR awardWashington business registrationY Combinator profile
SourcesOfficial websiteLinkedIn company pageY Combinator profileLSINW one-pagerCBInsights financialsCBInsights peopleSBIR awardPatent applicationWashington registrationProspeo company profileSalary.com profileMyVisaJobs employer profile

Jobs and careers at Sigma Genetics

0 jobs at Sigma Genetics

No open positions

Check back later for new openings

Explore startup hiring

Startup Hiring PulseBrowse all startup jobsJobs at Y Combinator startupsJobs at venture-backed startupsHealthcare startup jobs

Jobs with Startups © 2026

Browse jobsMCP guideAboutPowered by Supabase